"Designing Growth Strategies is in our DNA"

Australia and New Zealand Prothrombin Complex Concentrate Market Size, Share & Covid-19 Impact Analysis, By Product (4-factor PCC and 3-factor PCC), By Application (Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency and By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Others), 2020-2027

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI104761

 

  1. 1.Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Epidemiology of Coagulation Factor Deficiency in Australia and New Zealand
    2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
    3. Regulatory Scenario – For Key Countries
    4. Analysis in Relation to Alternatives to PCC
    5. PCC Market: Reimbursement Scenario & Key Industry Trends
    6. Impact of COVID-19 on PCC Market
  5. Australia & New Zealand Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  6. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
      1. CSL Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Grifols SA
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Octapharma AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Sanquin
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Kedrion S.p.A
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. Shire (Takeda Pharmaceutical Company Limited)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Other Players
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
  7. Strategic Recommendations
Read Less

Figure 1: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Product, 2019 & 2027

Figure 2: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 3: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (US$ Mn), by Application, 2019 & 2027

Figure 4: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 5: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (US$ Mn), by End User, 2019 & 2027

Figure 6: Australia & New Zealand Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 7: Global PCC Market Share Analysis (%), By Company, 2019

Table 1: Australia & New Zealand Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Product, 2016–2027

Table 2: Australia & New Zealand Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by Application, 2016–2027

Table 3: Australia & New Zealand Prothrombin Complex Concentrate Market Revenue (US$ Mn) Forecast, by End User, 2016–2027

Australia and New Zealand Prothrombin Complex Concentrate Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?